Skip to content

Association and mechanism study of lipoprotein(a) and its genetic polymorphism with adverse left ventricular remodeling after acute myocardial infarction

Association and mechanism study of lipoprotein(a) and its genetic polymorphism with adverse left ventricular remodeling after acute myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093888
Enrollment
Unknown
Registered
2024-12-13
Start date
2023-08-16
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ST-segment elevation myocardial infarction

Interventions

High Lp(a) group and Low Lp(a) group:N/A

Sponsors

Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for STEMI: meet both the criteria of elevated cardiac troponin (cTn) exceeding the upper limit of the normal reference value and new ischemic electrocardiogram changes with ST segment elevation. The criteria for ST segment elevation are as follows: a new ST segment elevation at the J point in two adjacent leads, with V2-V3 leads >=2.5 mm (male, =2.0 mm (male, >=40 years old); >= 1.5 mm (women, regardless of age); Other leads >=1.0 mm; 2.Attend within 24 hours of the onset of symptoms; 3.Receive primary percutaneous coronary intervention (PCI) treatment.

Exclusion criteria

Exclusion criteria: 1.Age <18 years old; 2.Severe valvular heart disease; 3.Unstable hemodynamics requiring mechanical circulatory supports, such as IABP or ECMO; 4.Previous history of HF or MI; 5.Severe liver or kidney dysfunction; 6.Severe infection, systemic inflammatory disease, or autoimmune disease; 7.Pregnant or lactating women; 8.Refused to sign the informed consent;

Design outcomes

Primary

MeasureTime frame
Adverse ventricular remodeling;

Secondary

MeasureTime frame
high-sensitivity C-reactive protein (hsCRP);Tumor Necrosis Factor (TNF-a);Interleukin 6 (IL-6);N-terminal pro brain natriuretic peptide (NT-proBNP);Hypersensitive troponin I (hsTnI);Galectin-3;Soluble growth stimulation expression gene 2 protein (sST2);Notch1;NF-?B;Cardiac indicators on CMR;

Countries

China

Contacts

Public ContactHuihui Liu

Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College

18810261721@163.com+86 10 88396885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026